Eyetech Pharmaceuticals Company
%20.jpg)
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.
Founded Date:
1-1
Last Funding Type:
Non-equity Assistance
Headquarters:
New York, New York, United States
Investors Number:
1
Technology:
Geroscience
Industry:
Biopharma, Biotechnology, Medical
Funding Status:
M&A
Investor Type:
For Profit